Literature DB >> 2641460

Preparation of a fine powder of 2-deoxy-2-[18F]fluoro-D-glucose suitable for inhalation to diagnose lung diseases by means of PET.

F Ojima1, T Ido, T Takahashi, J Hatazawa, M Ito, H Sasaki, M Yanai, T Aikawa, T Takishima, K Abiko.   

Abstract

Fine 2-deoxy-2-[18F]fluoro-D-glucose (18FDG) powder was obtained by adding diethyl ether into a methyl alcohol solution of 18FDG and other sugar as seed. When micronized particles of sodium N-acetyl-neuraminate (Neu5Ac-Na) were used as seed crystals, particles containing 18FDG were obtained and 80% of them were smaller than 10 microns in size. More than 60% of these crystals were 4-6 microns in size. In a preclinical study of forced inhalation in a dog, the 18FDG fine powder was mainly distributed in the trachea. The radioactivity in the trachea then increased once and a gradual decrease followed. The radioactivity was transferred into the blood and radioactivity incorporation into the heart was observed. After a normal volunteer inhaled 18FDG dry powder aerosol, the radioactivity was found in the respiratory tract and the peripheral area of the lung by means of PET. Absorption and in vivo dynamics of the 18FDG were also analysed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2641460     DOI: 10.1007/bf03178301

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  10 in total

1.  AG 11A8 ion-retardation resin. I. Separation of proteins from sodium chloride, buffer ions, and reagents used to deproteinize solutions.

Authors:  M L Reis; W Draghetta; L J Greene
Journal:  Anal Biochem       Date:  1977-08       Impact factor: 3.365

2.  A high efficiency ultrasound nebuliser for radioaerosol studies of the lungs.

Authors:  M Pillay; J A Akkermans; P H Cox
Journal:  Eur J Nucl Med       Date:  1987

Review 3.  Clinical aspects of mucociliary transport.

Authors:  A Wanner
Journal:  Am Rev Respir Dis       Date:  1977-07

4.  Dry powder aerosols. I. A new powder inhalation device.

Authors:  J H Bell; P S Hartley; J S Cox
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

5.  Site and nature of airway obstruction in chronic obstructive lung disease.

Authors:  J C Hogg; P T Macklem; W M Thurlbeck
Journal:  N Engl J Med       Date:  1968-06-20       Impact factor: 91.245

6.  Lung clearance mechanisms in obstructive airways disease.

Authors:  T Isawa; T Teshima; T Hirano; A Ebina; M Motomiya; K Konno
Journal:  J Nucl Med       Date:  1984-04       Impact factor: 10.057

7.  Relationship of smoking history and pulmonary function tests to tracheal mucous velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic bronchitis.

Authors:  R M Goodman; B M Yergin; J F Landa; M H Golivanux; M A Sackner
Journal:  Am Rev Respir Dis       Date:  1978-02

8.  Multistage liquid impinger.

Authors:  K R May
Journal:  Bacteriol Rev       Date:  1966-09

9.  Increased airway mucosal permeability of smokers. Relationship to airway reactivity.

Authors:  S M Kennedy; R K Elwood; B J Wiggs; P D Paré; J C Hogg
Journal:  Am Rev Respir Dis       Date:  1984-01

10.  Effects of histamine on lung permeability in normal and asthmatic subjects.

Authors:  P J Rees; D Shelton; T B Chan; N Eiser; T J Clark; M N Maisey
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.